Issue 41, 2013

Template-constrained cyclic sulfopeptide HIV-1 entry inhibitors

Abstract

Template-constrained cyclic sulfopeptides that inhibit HIV-1 entry were rationally designed based on a loop from monoclonal antibody (mAb) 412d. A focused set of sulfopeptides was synthesized using Fmoc-Tyr(SO3DCV)-OH (DCV = 2,2-dichlorovinyl). Three cyclic sulfopeptides that inhibit entry of HIV-1 and complement the activity of known CCR5 antagonists were identified.

Graphical abstract: Template-constrained cyclic sulfopeptide HIV-1 entry inhibitors

Supplementary files

Article information

Article type
Communication
Submitted
08 Jul 2013
Accepted
14 Sep 2013
First published
17 Sep 2013

Org. Biomol. Chem., 2013,11, 7096-7100

Template-constrained cyclic sulfopeptide HIV-1 entry inhibitors

J. G. Rudick, M. M. Laakso, A. C. Schloss and W. F. DeGrado, Org. Biomol. Chem., 2013, 11, 7096 DOI: 10.1039/C3OB41395K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements